medical Class II Updated 2021-07-28

Fresenius Medical Care Holdings, Inc. recalls Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concent

Recalled Product

Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be used as one component in the preparation of dialysate in a 3-stream proportioning hemodialysis machine according to a physician s prescription. Both concentrates are formulated for use in 45X proportioning systems which proportion a nominal ratio of 1 : 1.72 : 42.28 (acid : bicarbonate : water) to generate dialysate. The dialysate is intended to be pumped through a dialyzer, creating an osmotic gradient across the dialyzer membrane to exchange solutes with blood during hemodialysis.


Hazard / Issue

Exposed to freezing temperatures due to refrigerated truck malfunctions

Issued by

FDA

Affected States: TX
Lot/Code Info: Lot Number/UDI: (1) 21ATGF013 (01)00884086110135 0FD3251-3B (2) 20SXGF010 (01)00840861101597 0FD3251-3B (3) 20SXGF013 (01)00840861101597
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →